13 Results for "

GP41 fusion peptide

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "GP41 fusion peptide" in MCE Product Catalog:

Cat. No.: HY-P5497
Target:  

HIV

Research Areas:  

Others

C34 peptide is a biological active peptide. (This C34 peptide, also known as HR2, belongs to the helical region of gp41 of HIV, C-terminal heptad repeat 2 (HR2) defined as C helix or C peptide. It is known that HIV-1 enters cells by membrane fusion, C34 gp41 peptide is a potent inhibitors of HIV-1 fusion.)
loading...
    loading...
Cat. No.: HY-P1753
CAS No.: 943790-62-3
Target:  

HIV

Research Areas:  

Infection

VIR-165 is a modified form of virus inhibitory peptide (VIRIP) that binds the fusion peptide of the gp41 subunit and prevents its insertion into the target membrane. VIRIP inhibits a wide variety of human immunodeficiency virus type 1 (HIV-1) strains .
loading...
    loading...
Cat. No.: HY-P5498
Target:  

HIV

Research Areas:  

Others

N36 peptide is a biological active peptide. (HIV-1 gp41 fusion peptide)
loading...
    loading...
Cat. No.: HY-P10820
Target:  

HIV

Research Areas:  

Infection

N36Mut(e,g) is a gp41-targeted HIV fusion peptide inhibitor. N36Mut(e,g) acts by disrupting the homotrimeric coiled-coil of N-terminal helices in the pre-hairpin intermediate to form heterotrimers .
loading...
    loading...
Cat. No.: HY-P10437
CAS No.: 339332-64-8
Synonyms: human α1-AT(353-372)
Target:  

HIV

Research Areas:  

Infection

VIRIP (human α1-AT(353-372)) is a HIV-1 inhibitor. VIRIP blocks the entry of HIV-1 by interacting with gp41 fusion peptide. VIRIP can be used for virus research .
loading...
    loading...
Cat. No.: HY-P1566
CAS No.: 395069-92-8
Target:  

HIV

Research Areas:  

Infection

MPG, HIV related is 27-aa peptide, derived from both the nuclear localisation sequence of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41 and is a potent delivery agent for the generalised delivery of nucleic acids and of oligonucleotides into cultured cells.
loading...
    loading...
Cat. No.: HY-P11037
Target:  

HIV

Research Areas:  

Infection

soVIRIP is a virus inhibitory peptide with an IC50 of 1.2  μM for HIV-1 . soVIRIP binds to the HIV-1 GP41 fusion peptide and inhibits viral fusion and entry into host cells. soVIRIP has broad-spectrum anti-HIV-1 activities with nontoxicity in zebrafish models. soVIRIP can used for viral infections research .
loading...
    loading...
Cat. No.: HY-172713
Target:  

Liposome

Research Areas:  

Infection

DSPE-PEG1000-MPG is a PEG compound which composed of DSPE and a peptide vector (MPG). MPG is derived from both the nuclear localisation sequence (NLS) of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41. MPG could deliver short oligonucleotides into cells efficiently and independently of the endosomal pathway .
loading...
    loading...
Cat. No.: HY-172714A
Target:  

Liposome

Research Areas:  

Infection

DSPE-PEG3400-MPG is a PEG compound which composed of DSPE and a peptide vector (MPG). MPG is derived from both the nuclear localisation sequence (NLS) of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41. MPG could deliver short oligonucleotides into cells efficiently and independently of the endosomal pathway .
loading...
    loading...
Cat. No.: HY-172715
Target:  

Liposome

Research Areas:  

Infection

DSPE-PEG5000-MPG is a PEG compound which composed of DSPE and a peptide vector (MPG). MPG is derived from both the nuclear localisation sequence (NLS) of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41. MPG could deliver short oligonucleotides into cells efficiently and independently of the endosomal pathway .
loading...
    loading...
Cat. No.: HY-P11353
CAS No.: 117138-19-9
Research Areas:  

Infection Cancer

HA2 peptide is a potent pH-responsive fusion peptide derived from hemagglutinin (HA), corresponding to the N-terminal fusion peptide domain consisting of 23 amino acid residues of HIV-1 gp41 envelope glycoprotein. HA2 peptide adopts a random coil structure under physiological pH conditions; in acidic endosomes, protonation of carboxyl groups reduces negative charge, inducing a transition to an α-helical conformation that can fuse with and destabilize the endosomal membrane. After binding to membranes, the N-terminal and middle regions of HA2 peptide mainly adopt a β-strand conformation, while the C-terminal region remains unstructured. HA2 peptide induces lipid mixing and promotes aqueous content leakage from large unilamellar vesicles whose lipid composition matches that of HIV-1 viruses and target T cells. HA2 peptide is anionic and can bind to cationic peptides to achieve siRNA condensation. HA2 peptide can be used in studies related to cancer and human immunodeficiency virus (HIV) infection .
loading...
    loading...
Cat. No.: HY-172714
Target:  

Liposome

Research Areas:  

Infection

DSPE-PEG2000-MPG is a PEG compound which composed of DSPE and a peptide vector (MPG). MPG is derived from both the nuclear localisation sequence (NLS) of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41. MPG could deliver short oligonucleotides into cells efficiently and independently of the endosomal pathway .
loading...
    loading...
Cat. No.: HY-187486A
Synonyms: DOPE-PEG2000-Mal-Cys-MPG
Research Areas:  

Others

DOPE-PEG2000-MPG (DOPE-PEG2000-Mal-Cys-MPG) is an amphiphilic lipid-PEG-peptide conjugate consisting of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the MPG peptide, a cell-penetrating peptide derived from the HIV-1 gp41 fusion peptide and the nuclear localization sequence (NLS) of SV40 large T antigen. DOPE-PEG2000-MPG is used for intracellular delivery of siRNA, DNA, and other macromolecules.
loading...
    loading...
  • 1